best practices for topical generic product development & anda submission–session 3, closing remarks
Published 2 years ago • 648 plays • Length 58:05Download video MP4
Download video MP3
Similar videos
-
54:12
best practices for topical generic product development and anda submission – session 2
-
1:01:29
best practices for topical generic product development and anda submission–introduction & session 1
-
6:07
advancing generic drug development: translating science to approval, day one closing remarks
-
19:39
strategies for generic topical product development (7of35) complex generics– sep. 25-26, 2019
-
19:56
pbpk to guide study design and product development for generic dermatological products
-
13:58
guidance for industry: referencing approved drug products in anda submissions
-
18:34
patent dispute and best practices for 505(b)(2) and anda applicants – panel discussion
-
16:19
referencing approved drug products in anda submissions (9of28) generic drugs forum – apr. 3-4, 2019
-
1:54:43
advancing generic drug development translating science to approval day 1–session 4 & closing remarks
-
17:27
pre-anda review: office of pharmaceutical quality (opq) (4of39) complex generics 2018
-
1:57:52
complex generics: topical products, part 1
-
1:28:19
session 4 talks, panel, closing remarks
-
1:31:52
complex generics: topical products, part 2
-
16:44
generic labeling: strategies for providing high-quality submissions (18/28) generic drugs forum 2017
-
11:47
good anda submission and assessment practices and software support (5of27) generic drugs forum 2018
-
1:23:36
advancing generic drug development: translating science to approval 2023 – day 1 – part 1
-
30:26
best practices for conducting bioequivalence studies (16of27) generic drugs forum 2018
-
4:55
product specific guidances - closing remarks
-
13:21
overview of the fda product-specific guidance program